Amrita M. Nargund - Concepedia

Author

Amrita M. Nargund

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Amrita M Nargund, Amrita M. Nargund, Amrita Nargund, Amrita M. Nargund, Nargund, Amrita

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Molecular Oncology (United States)National University of Singapore Washington University in St. Louis

About

Amrita M. Nargund is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2.2K
2	Cell Biology	6	6	1.3K
3	Natural Sciences	3	3	1.6K
4	Health Sciences	1	1	123
5	Biochemistry	1	1	54

Amrita M. Nargund

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Mitochondrial Import Efficiency of ATFS-1 Regulates Mitochondrial UPR Activation Amrita M. Nargund, Mark W. Pellegrino, Christopher J. Fiorese, Science Reductive StressTranscriptional RegulationSystems BiologySignal TransductionMitochondrial Function	2012	1K
Mitochondrial and Nuclear Accumulation of the Transcription Factor ATFS-1 Promotes OXPHOS Recovery during the UPRmt Amrita M. Nargund, Christopher J. Fiorese, Mark W. Pellegrino, Molecular Cell Reductive StressMitochondrial FunctionMitochondrial DynamicNuclear AccumulationGenetics	2015	460
Mitochondrial UPR-regulated innate immunity provides resistance to pathogen infection Mark W. Pellegrino, Amrita M. Nargund, Natalia V. Kirienko, Nature Host ResponsePathogenesisImmunologyInnate Immune SystemInnate Immunity	2014	376
Protective Coupling of Mitochondrial Function and Protein Synthesis via the eIF2α Kinase GCN-2 Brooke M. Baker, Amrita M. Nargund, Tiffany Sun, PLoS Genetics	2012	316
The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma Amrita M. Nargund, Can G. Pham, Yiyu Dong, Cell Reports	2017	215
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma Jozefina Casuscelli, Nils Weinhold, Gunes Gundem, JCI Insight Chrcc PatientsPathologyTumor BiologyChromosome DuplicationGenitourinary Cancer	2017	123
SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes Yuchen Xie, Merve Şahin, S. K. Sinha, Nature Cancer ChromatinSetd2 LossChromatin RemodelingMedicineEpigenetic Change	2022	74
Cadmium induces a heterogeneous and caspase-dependent apoptotic response in Saccharomyces cerevisiae Amrita M. Nargund, Simon V. Avery, John E. Houghton APOPTOSIS BiochemistrySaccharomyces CerevisiaeNatural SciencesMetalloproteinBioactive Metal	2008	54
The C. elegans CCAAT-Enhancer-Binding Protein Gamma Is Required for Surveillance Immunity Kirthi C. Reddy, Tiffany L. Dunbar, Amrita M. Nargund, Cell Reports Ccaat-enhancer-binding Protein GammaMicrobial PathogensInnate Immune SystemImmunologyImmunologic Mechanism	2016	52
Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent <i>CCNE1</i> and <i>IGF2</i> enhancer hijacking in primary gastric adenocarcinoma Wen Fong Ooi, Amrita M. Nargund, Kevin Lim, Gut	2019	50

Page 1